Pharmacology of cancer chemotherapy drugs for hyperthermic intraperitoneal peroperative chemotherapy in epithelial ovarian cancer

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 2, Issue 4

This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

506

HTML

3477

Figures (1-6)

184

Tables (1-1)

171

Sum=4338

Publishing Process of This Article

Item

Count

Browse

1135

Download

977

Sum=2112

Nov 10, 2013 (publication date) through Aug 26, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Obstetrics and Gynecology

ISSN

2218-6220

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Obstet Gynecol. Nov 10, 2013; 2(4): 143-152
Published online Nov 10, 2013. doi: 10.5317/wjog.v2.i4.143

Full Size Figure Download Figure

Figure 5 Pharmacologic concept of bidirectional intravenous and intraperitoneal chemotherapy. Modified from Fujiwara et al[69].

Citation: Speeten KVD, Stuart AO, Sugarbaker PH. Pharmacology of cancer chemotherapy drugs for hyperthermic intraperitoneal peroperative chemotherapy in epithelial ovarian cancer. World J Obstet Gynecol 2013; 2(4): 143-152
URL: https://www.wjgnet.com/2218-6220/full/v2/i4/143.htm
DOI: https://dx.doi.org/10.5317/wjog.v2.i4.143